Elidel (pimecrolimus) cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild-to-moderate AD in non-immunocompromised adults and children 2 years of age and older, who failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable.
Protopic (tacrolimus) ointment, both 0.03% and 0.1% for adults and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate-to-severe atopic dermatitis in non-immunocompromised adults and children who failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable.